Schneider, T., Luethi, J., Mauermann, E., Bandschapp, O., and Ruppen, W. (2019). Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Adult Males. Anesthesiology.
Koppert, W., Filitz, J., Troster, A., Ihmsen, H., Angst, M., Flor, H., Schuttler, J., and Schmelz, M. (2005a). Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. J Pain. 6, 757-764.
Koppert, W., Ihmsen, H., Korber, N., Wehrfritz, A., Sittl, R., Schmelz, M., and Schuttler, J. (2005b). Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 118, 15-22.
Koppert, W., Wehrfritz, A., Korber, N., Sittl, R., Albrecht, S., Schuttler, J., and Schmelz, M. (2004). The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 108, 148-153.
Chizh, B.A., Dusch, M., Puthawala, M., Schmelz, M., Cookson, L.M., Martina, R., Brown, J., and Koppert, W. (2004). The effect of intravenous infusion of adenosine on electrically evoked hyperalgesia in a healthy volunteer model of central sensitization. Anesth Analg 99, 816-822.
Klede, M., Handwerker, H.O., and Schmelz, M. (2003b). Central origin of secondary mechanical hyperalgesia. J.Neurophysiol. 90, 353-359.
Koppert, W., Sittl, R., Scheuber, K., Alsheimer, M., Schmelz, M., and Schuttler, J. (2003b). Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 99, 152-159.
Angst, M.S., Koppert, W., Pahl, I., Clark, D.J., and Schmelz, M. (2003). Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106, 49-57.
Koppert, W., Angst, M., Alsheimer, M., Sittl, R., Albrecht, S., Schüttler, J., and Schmelz, M. (2003a). Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain 106, 91-99.
Koppert, W., Dern, S.K., Sittl, R., Albrecht, S., Schuttler, J., and Schmelz, M. (2001). A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology. 95, 395-402.
Folgen Sie uns
Dermal Dialysis Impressum: Dr. med. Steffi Escher, Am Sonnigen Hang 8, 68259 Mannheim, Germany info@dermaldialysis.de, German Tax identification number: DE229313244